Paying Hackers and Turning Tech Against Cancer: HRA Today

HCA News Staff
FEBRUARY 09, 2018

When SamSam ransomware struck an Indiana hospital, the decision makers there faced a troubling dilemma: to pay or not to pay? In this week’s episode of HRA Today, your host and market research analyst Jyoti Parmar outlines the problem that Hancock Health faced earlier this year and what the institution ultimately did.

What was at stake, according to Parmar: $47,000 in bitcoin—along with patient data. But there are also more sweeping questions surrounding the payment of ransom to hackers. How, for instance, can healthcare expect to stop this scourge when ransomware actually succeeds? The incident also shined a light on an often-overlooked obstacle surrounding backup files.

For more information, watch the video above or click here to read our insider story on what went into the process.

By now, most healthcare leaders understand that chimeric antigen receptor (CAR) T-cell therapies are clawing their way to prominence. Yes, it will likely take plenty of time—and many more clinical trials and FDA approvals—before CAR T becomes ubiquitous in terms of what it can treat, meaning that it will mostly be reserved for high-end academic medical centers, at least for now, according to experts.

But it’s smart for hospital honchos to begin considering how big data, analytics, and emerging technologies could foster the implementation and improvement of CAR T-cell therapies in their facilities.

We published a cover story on this late last year, and it’s certainly worth the read. What’s more, as Parmar mentions, HRA is hosting a webinar on this very topic. For more information, click here.

Finally, this episode of HRA Today features a rundown of some upcoming blue-chip conferences and events. Don’t be the last to know.

Become a contributor